By sending nanoemulsion formulations on a space flight, scientists are investigating whether chitosan—a material derived from ...
Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...
4d
Zacks Investment Research on MSNAMGN's Eczema Drug Meets Goal in Two Late-Stage StudiesAmgen AMGN announced positive results from two clinical studies, IGNITE and SHUTTLE, which are part of the phase III ROCKET ...
We came across a bullish thesis on Rocket Pharmaceuticals, Inc. (RCKT) on Twitter by sharkbiotech. In this article, we will ...
Varda, a US firm planning to manufacture pharmaceuticals in low Earth orbit, is expecting its second capsule to return to ...
Scientists are exploring a new way to deliver medicine in space using chitosan, a material made from shrimp shells. Chitosan ...
Rocket Pharmaceuticals ... There are no approved drugs for the disease. Besides RP-L201, Orchard Therapeutics used to run tests on a drug called OTL-103 in the indication. However, since its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results